Disc Medicine, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Disc Medicine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Disc Medicine, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.9M, a 73.3% decline year-over-year.
  • Disc Medicine, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$125M, a 63.4% decline year-over-year.
  • Disc Medicine, Inc. annual Operating Income (Loss) for 2023 was -$91.1M, a 91.9% decline from 2022.
  • Disc Medicine, Inc. annual Operating Income (Loss) for 2022 was -$47.5M, a 53.5% decline from 2021.
  • Disc Medicine, Inc. annual Operating Income (Loss) for 2021 was -$30.9M, a 9.13% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$91.1M -$43.7M -91.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$47.5M -$16.5M -53.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$30.9M +$3.11M +9.13% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$34M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.